2016-01~Present - Chinese Academy of Sciences - Distinguished Researcher
2013-01~Present - ShanghaiTech University - Distinguished Professor
2007-01~Present - Shanghai Pasteur Institute, Chinese Academy of Sciences - Researcher, Group Leader, Assistant Director
2003-09~2006-12 - Scripps Research Institute - Postdoctoral Research Assistant
2015: 'Emergences' Award by the French Embassy in China
2014: Excellent Graduate Student Supervisor Award by the Chinese Academy of Sciences
2013: State Council Special Allowance Expert
2012: Outstanding Young Scientific and Technological Innovation Talent Nomination Award by the Shanghai Branch of the Chinese Academy of Sciences
2012: Zhu Li Yuehua Excellent Teacher Award by the Chinese Academy of Sciences
2010: Outstanding Young Talent by the Chinese Academy of Sciences
2009: French Talent Innovation Award
Research
Virology Immunology Antiviral Drug Screening
Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent, Yifan Xing, Ran Chen, Feng Li, Bin Xu, Lin Han, Chaolun Liu, Yimin Tong, Yaming Jiu, Jin Zhong, GuoChun Zhou, 2023
Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance, Chaolun Liu, Mingzhe Guo, Lin Han, Jie Lu, Xiaogang Xiang, Qing Xie, Janin Nouhin, Veasna Duong, Yimin Tong, Jin Zhong, 2023
Identification of a novel replication-competent hepatitis C virus variant that confers the sofosbuvir resistance, Leumi, Steve, Guo, Mingzhe, Lu, Jie, Wang, Zhaoning, Gan, Tianyu, Han, Lin, Ngari, Jackline, Tong, Yimin, Xiang, Xiaogang, Xie, Qing, Wang, Lanfeng, Zhong, Jin, 2022
Inhibitor Development against p7 Channel in Hepatitis C Virus, Wei, Shukun, Hu, Xiaoyou, Du, Lingyu, Zhao, Linlin, Xue, Hongjuan, Liu, Chaolun, Chou, James J, Zhong, Jin, Tong, Yimin, Wang, Shuqing, OuYang, Bo, 2021
Junctional and somatic hypermutation-induced CX4C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody, Yi, Chunyan, Xia, Jing, He, Lan, Ling, Zhiyang, Wang, Xuesong, Yan, Yu, Wang, Jiangjun, Zhao, Xinhao, Fan, Weiguo, Sun, Xiaoyu, Zhang, Ronghua, Ye, Sheng, Zhang, Rongguang, Xu, Yongfen, Ma, Liyan, Zhang, Yaguang, Zhou, Honglin, Huang, Zhong, Niu, Junqi, Long, Gang, Lu, Junxia, Zhong, Jin, Sun, Bing, 2021
TRIM26 is a critical host factor for HCV replication and contributes to host tropism, Liang, Yisha, Zhang, Guigen, Li, Qiheng, Han, Lin, Hu, Xiaoyou, Guo, Yu, Tao, Wanyin, Zhao, Xiaomin, Guo, Mingzhe, Gan, Tianyu, Tong, Yimin, Xu, Yongfen, Zhou, Zhuo, Ding, Qiang, Wei, Wensheng, Zhong, Jin, 2021
Glycometabolism regulates hepatitis C virus release, Tao Yu, Qiankun Yang, Fangling Tian, Haishuang Chang, Zhenzheng Hu, Bowen Yu, Lin Han, Yifan Xing, Yaming Jiu, Yongning He, Jin Zhong, 2021
Corrigendum to 'DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication' Virology 435 (2013) 385–394, Xi Kang, Xi Chen, Ying He, Deyin Guo, Lin Guo, Jin Zhong, HongBing Shu, 2021
UNC93B1 curbs cytosolic DNA signaling by promoting STING degradation, He, Zhenliang, Ye, Sichao, Xing, Yifan, Jiu, Yaming, Zhong, Jin, 2021
Hepatitis C virus genotype 4: A poorly characterized endemic genotype, Leumi, Steve, El Kassas, Mohamed, Zhong, Jin, 2021
A novel cell culture system modeling the SARS-CoV-2 life cycle, Ju, Xiaohui, Zhu, Yunkai, Wang, Yuyan, Li, Jingrui, Zhang, Jiaxing, Gong, Mingli, Ren, Wenlin, Li, Sai, Zhong, Jin, Zhang, Linqi, Zhang, Qiangfeng Cliff, Zhang, Rong, Ding, Qiang, 2021
Development of a New Reverse Genetics System for Ebola Virus, Tianyu Gan, Dihan Zhou, Yi Huang, Shuqi Xiao, Ziyue Ma, Xiaoyou Hu, Yimin Tong, Huimin Yan, Jin Zhong, 2021
Cryo-EM structures of Lassa and Machupo virus polymerases complexed with cognate regulatory Z proteins identify targets for antivirals, Xu, Xin, Peng, Ruchao, Peng, Qi, Wang, Min, Xu, Ying, Liu, Sheng, Tian, Xiaolin, Deng, Haiteng, Tong, Yimin, Hu, Xiaoyou, Zhong, Jin, Wang, Peiyi, Qi, Jianxun, Gao, George F, Shi, Yi, 2021
DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication (vol 435, pg 385, 2013), Kang, Xi, Chen, Xi, He, Ying, Guo, Deyin, Guo, Lin, Zhong, Jin, Shu, HongBing, 2021
Area of Focus
Antiviral | Drug Design | Pharmacology | Virology | Sars-Cov-2 | Covid-19 | Protease Inhibitors | Chemical Components | Traditional Chinese Medicine | Influenza